Lineage Cell Therapeutics (LCTX) Other Accumulated Expenses (2011 - 2023)
Lineage Cell Therapeutics' Other Accumulated Expenses came in at $1,000 for Q2 2023, down 90.0% from $10,000 a year earlier and down 97.3% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Other Accumulated Expenses (2011 - 2023) Analysis & Trends
At the end of FY2021, Lineage Cell Therapeutics' Other Accumulated Expenses was $178,000.
- Other Accumulated Expenses carries a five-year compound annual growth rate of -16.4% (FY2016 to FY2021).
- Going back by year, Other Accumulated Expenses was $9,000 in FY2020 (+125.0%), $4,000 in FY2019 (-55.6%), $9,000 in FY2018 (-93.4%) and $137,000 in FY2017 (-68.5%).
- The Q2 2023 figure represents the lowest quarterly Other Accumulated Expenses in data going back to Q4 2011.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2021 (growth of 706.6%), and the weakest in Q2 2022 (a decline of 98.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 78,000.00 |
| Dec 31, 2021 | 178,000.00 |
| Sep 30, 2021 | 69,000.00 |
| Jun 30, 2021 | 492,000.00 |
| Mar 31, 2021 | 179,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 61,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 76,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | 9,000.00 |
| Jun 30, 2018 | 102,000.00 |
| Mar 31, 2018 | 292,000.00 |
| Dec 31, 2017 | 137,000.00 |
API Access
Lineage Cell Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();